However, vitamin D receptor activation in cancer-associated fibroblasts can eliminate CAF-derived IL-8 mediated GC oxaliplatin resistance in GC by blocking PI3K/Akt signaling, which provides a promising basis for overcoming GC drug resistance in clinical practice (82). The gene discussed is VDR; the disease is cancer.